May 5, 2020 / 1:17 PM / a month ago

BRIEF-Amgen Inc Says Kyprolis Patents Upheld Against Generic Manufacturer

May 5 (Reuters) - Amgen Inc:

* AMGEN INC - KYPROLIS (CARFILZOMIB) PATENTS UPHELD AGAINST GENERIC MANUFACTURER

* AMGEN - DECISION WILL PREVENT CIPLA FROM MAKING, USING, SELLING OR IMPORTING GENERIC VERSION OF KYPROLIS UNTIL EXPIRATION OF PATENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below